Diabetes Information

Diabetic Complications - Can Benfotiamine Help Prevent Them?


Diabetic complications contribute too many life threatening diseases globally. The root cause of diabetic complications is elevated glucose levels which contribute to blood vessel damage. Diabetic retinopathy, nephropathy, or neuropathy are caused by damage to small blood vessel in the eyes, nerves and kidneys, etc. The bottom line of this damage is the lowering of the life expectancy of millions of diabetics worldwide.

What Can Be Done About It?

Few therapies are available today that treat diabetic complications. Most healthcare professionals recommend that their patients monitor their blood sugar by taking several blood readings a day to determine the amount of sugar in their blood. Blood sugar readings are generally higher from one to two hours after a meal.

It is suggested by these professionals that keeping blood sugar readings as close to normal as possible will reduce the onset of diabetic complications. Research has shown that there are four, chemical pathways that lead to diabetic complications. Instead of trying to explain these rather difficult chemical pathways, let the reader understand that diabetic complications are mainly caused by excess sugar in the cells, a condition known by the term advanced glycation endproducts (AGE) formation.

The research that was released in 2003 by a team of researchers from the Albert Einstein Collage of Medicine opened the possibilities that it may be possible to actually prevent and/or contain diabetic complications such as retinopathy, neuropathy and heart/circulatory conditions brought about by the presence of advanced glycation endproducts.

What Did This Research Suggest?

The Einstein researchers' work showed that a substance called, "benfotiamine", could reduce the effects of AGE by increasing the amount of an enzyme called transketolase. The research indicated that transketolase was increased by 300% which was enough to make a serious reduction of three of the four chemical pathways that open the door for diabetic complications in terms of vascular damage in diabetics. This vascular damage is directly responsible for the diabetic complications such as neuropathy, retinopathy and heart/circulatory conditions that lead to heart attack and stroke.

Can Benfotaimine Be Considered A Prudent Preventative?

Current research suggests that benfotiamine could possibly reduce the chances of diabetics developing the aforementioned complications. Many healthcare professionals readily recommend patients to add this nutritional supplement to their toolkit in the battle to prevent these insidious conditions that shorten the lives of thousands of diabetics annually.

Where Can I Find More Information About Benfotiamine?

More information about benfotiamine can be found by visiting the web site below and following the links. These links will give the reader a good base to make an informed decision about the use of benfotiamine in the battle against diabetic complications brought about by the presence of advanced glycation endproducts (AGE) which is excess sugar in the blood.

Research:

Hans-Peter Hammes, Xueliang Du, Diane Edelstein, Tetsuya Taguchi, Takeshi Matsumura, Qida Ju, Jihong Lin, Angelika Bierhaus, Peter Nawroth, Dieter Hannak, Michael Neumaier, Regine Bergfeld, Ida Giardino, Michael Brownlee. Benfotiamine blocks three major pathways of hyperglycemic damage and prevents experimental diabetic retinopathy. Nature Medicine 9, 294 - 299 (01 Mar 2003).

Michael Brownlee. Biochemistry and molecular cell biology of diabetic complications Nature 414, 813 - 820 (13 Dec 2001).

Roya Babaei-Jadidi, Nikolaos Karachalias, Naila Ahmed, Sinan Battah, Paul J. Thornalley. Prevention of incipient diabetic nephropathy by high-dose thiamine and benfotiamine - Complications. Diabetes. (August 2003).

Zach Malott is CEO of Brentwood Health International, a nutritional supplement company involved in distribution and supplying wholesale, retail and end users.

Mr. Malott is available to discuss the research as it applies to benfotiamine in the treatment and prevention of diabetic complications such as neuropathy and retinopathy.

He can be reached at:

Phone: 505.354.0526

Website: http://www.emuhealthproducts.com


MORE RESOURCES:

Astra seeks approval for diabetes drug
Forbes, NY - Jul 23, 2008
The two companies began collaborating in January 2007 to develop and sell two investigational drugs for type 2 diabetes, saxagliptin and dapagliflozin. ...
Approval sought for diabetes drug The News Journal
Bristol-Myers Squibb and AstraZeneca Submit New Drug Application ... Business Wire (press release)
Bristol-Myers Squibb, AstraZeneca submit market clearance ... RTT News
Pharma Times (subscription) - PR-Inside.com (Pressemitteilung)
all 25 news articles


Ontario Now

Ontario Pledges $741 Million Against Diabetes, Including Funding ...
Diabetes Health (press release), CA - 6 hours ago
The provincial government of Ontario has announced it will spend $741 million over the next four years to combat diabetes, including paying the costs of ...
Hundreds of locals have Type 1 diabetes Orillia Packet & Times
Ontario to invest $741 million in diabetes treatment and prevention The Canadian Press
Ontario Will Pay For Insulin Pumps For Adult Diabetes Type 1 Patients Medical News Today
Reuters - AHN
all 74 news articles


Twofold Action Urged for Pre-Diabetes
Washington Post, United States - Jul 23, 2008
Pre-diabetes occurs when blood sugar levels or impaired glucose tolerance is elevated, but not quite to the point defined as diabetes. ...


First-line antihypertensive treatment in patientswith pre-diabetes ...
7thSpace Interactive (press release), NY - 3 hours ago
Recent clinical trials reported conflicting results on the reduction of new-onset diabetes using RAS blocking agents. Therefore the role of these agents in ...


New Consumer Guide in Spanish Helps Type 2s Compare Diabetes Drugs
Diabetes Health (press release), CA - 6 hours ago
A new Spanish language consumer guide to type 2 diabetes, called “Pastillas para la diabetes tipo 2,” has been released by the Agency for Healthcare ...
$300 Million for Type 1 Research: Congress Overrides Bush's Veto ... Diabetes Health (press release)
all 2 news articles


Endocrinologists Issue Consensus Statement on Pre-Diabetes
MedPage Today, NJ - 11 hours ago
By Todd Neale, Staff Writer, MedPage Today JACKSONVILLE, Fla., July 24 -- The treatment of pre-diabetes requires intensive lifestyle modification and the ...


Daily Mail

Fruit juice and type 2 diabetes
NHS Choices, UK - 15 hours ago
“Fruit juice ‘is diabetes risk’” is the headline in The Sun. “A daily glass of ‘healthy’ orange juice could actually increase the risk of diabetes,” the ...
Just one glass of orange juice a day could increase risk of diabetes Daily Mail
all 4 news articles


ABC News

Pre-Diabetes Must Be Treated, Doctors Urge
ABC News - Jul 23, 2008
By Mary Brophy Marcus Diabetes experts created the first recommendations Tuesday for the treatment of people with pre-diabetes in the hopes of curbing the ...


Diabetes Experts Recommend One-Two Punch for Treating Patients ...
MarketWatch - Jul 23, 2008
WASHINGTON, Jul 23, 2008 (BUSINESS WIRE) -- For the first time, a consensus of diabetes and metabolic disorder experts have recommended a comprehensive ...


eMaxHealth.com

Research Says Get Pre-Diabetes Treatment Soon
eMaxHealth.com, NC - 13 hours ago
Researchers suggest that pre-diabetes must be treated aggressively because if the treatment is not provided early it will cause health and financial ...

Diabetes - Google News

home | site map
© 2006